Skip to content
Screener

Merit Medical Systems MMSI Contingent consideration fair value adjustments

Contingent consideration fair value adjustments at other companies

TFX
TeleflexTFX
-$67K-100%
Boston Scientific logo
Boston ScientificBSX
-$30M-700%
Artivion logo
ArtivionAORT
$7.97M+204%
IAR
Integra LifeSciencesIART
Stereotaxis logo
StereotaxisSTXS
CONMED logo
CONMEDCNMD

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$5.32B+7.7%
Enterprise value$5.65B+4.3%
P/E38.2×-3.3×
P/S3.5×0.0×

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The source filing: Merit Medical Systems’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:23 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000856982-26-000025
Line itemThree Months Ended / March 31, 2026Three Months Ended / March 31, 2025
Loss on sale or abandonment of property and equipment6787
Write-off of certain intangible assets and other long-term assets13732
Amortization of right-of-use operating lease assets2,8542,984
Fair value adjustments related to contingent consideration liabilities(179)1,023
Amortization of deferred credits(26)(26)
Amortization of long-term debt issuance costs1,4141,414
Stock-based compensation expense8,9619,078
Changes in operating assets and liabilities, net of acquisitions and divestitures:

Item 1. Financial Statements (Unaudited)

FAQ

What is Merit Medical Systems's contingent consideration fair value adjustments?
Merit Medical Systems (MMSI) reported contingent consideration fair value adjustments of -$179K in Q1 2026.
How has Merit Medical Systems's contingent consideration fair value adjustments changed year-over-year?
Merit Medical Systems's contingent consideration fair value adjustments decreased by 117.5% year-over-year, from $1.02M to -$179K.

Ask your AI about Merit Medical Systems's contingent consideration fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude